
Loading, please wait...

Loading, please wait...

The C-GALL randomized trial compared laparoscopic cholecystectomy with conservative management in adults with uncomplicated symptomatic gallstone disease. The study addressed a practical question faced frequently in general surgery: does every patient with uncomplicated symptomatic gallstones benefit from immediate operation? At 18 months, the trial did not find a significant difference in the prespecified measure of bodily pain between the two strategies. Importantly, however, many patients who initially chose conservative management eventually crossed over to surgery, showing that non-operative care does not necessarily eliminate the future need for cholecystectomy. For surgeons, the study supports more individualized decision-making rather than assuming that surgery is automatically required in every uncomplicated symptomatic case. Patient symptoms, impact on daily life, preferences, recurrence risk, access to follow-up and willingness to undergo later surgery all matter. C-GALL is particularly relevant to shared decision-making. Conservative management can be a reasonable option for selected patients, provided they receive clear information about the possibility of persistent or recurrent symptoms and subsequent surgery. The study also demonstrates why surgical policy should be based on patient-centred outcomes rather than operative feasibility alone. The practical message is to distinguish uncomplicated symptomatic disease from complicated gallstone presentations where urgent or definitive surgical management remains essential.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


The C-GALL randomized trial compared laparoscopic cholecystectomy with conservative management in adults with uncomplicated symptomatic gallstone disease. The study addressed a practical question faced frequently in general surgery: does every patient with uncomplicated symptomatic gallstones benefit from immediate operation? At 18 months, the trial did not find a significant difference in the prespecified measure of bodily pain between the two strategies. Importantly, however, many patients who initially chose conservative management eventually crossed over to surgery, showing that non-operative care does not necessarily eliminate the future need for cholecystectomy. For surgeons, the study supports more individualized decision-making rather than assuming that surgery is automatically required in every uncomplicated symptomatic case. Patient symptoms, impact on daily life, preferences, recurrence risk, access to follow-up and willingness to undergo later surgery all matter. C-GALL is particularly relevant to shared decision-making. Conservative management can be a reasonable option for selected patients, provided they receive clear information about the possibility of persistent or recurrent symptoms and subsequent surgery. The study also demonstrates why surgical policy should be based on patient-centred outcomes rather than operative feasibility alone. The practical message is to distinguish uncomplicated symptomatic disease from complicated gallstone presentations where urgent or definitive surgical management remains essential.
Yesterday

The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back

A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back

Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back

A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back

A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back